Annual Report

Overview

The report presents Bharat Parenterals Limited's FY 2021-22 consolidated financial statements, with Revenue From Operations of 21,201.46 RS. LAKHS. It reports CSR cash expenditure of 65.31 RS. LAKHS and describes the group's subsidiary activities, including Innoxel Lifesciences' contract manufacturing, research and development, and commercial-supply plans.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services